Pharming Group to participate in April investor conferences

Rhea-AI Summary

Pharming Group (Euronext: PHARM/Nasdaq: PHAR) has announced its participation in two major investor conferences in April 2025:

• Van Lanschot Kempen Life Sciences Conference in Amsterdam, Netherlands (April 2-3, 2025)
• 24th Annual Needham Virtual Healthcare Conference (April 7-10, 2025)

At the Needham conference, CEO Fabrice Chouraqui and CMO Anurag Relan will deliver a presentation on April 8 at 10:15 am ET/16:15 CET. The presentation will be available via live webcast and replay on Pharming's website under the 'Upcoming Events' and 'News' sections. Interested parties can schedule one-to-one meetings with management through Pharming's IR team or conference representatives.

Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of April:

• Van Lanschot Kempen Life Sciences Conference 2025, Amsterdam, NL, April 2-3, 2025
• 24th Annual Needham Virtual Healthcare Conference, April 7-10, 2025
  Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present on Tuesday, April 8 at 10:15 am ET/16:15CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.

For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Van Lanschot Kempen or Needham representative.

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

• Pharming attending Investor Conferences April 2025_EN_28MAR25

FAQ

When is Pharming Group (PHARM) presenting at the Needham Healthcare Conference 2025?

Pharming Group will present at the Needham Healthcare Conference on Tuesday, April 8, 2025, at 10:15 am ET/16:15 CET.

Which investor conferences will Pharming Group (PHARM) attend in April 2025?

Pharming Group will attend the Van Lanschot Kempen Life Sciences Conference in Amsterdam (April 2-3) and the 24th Annual Needham Virtual Healthcare Conference (April 7-10).

How can investors access Pharming Group's (PHARM) Needham Conference presentation?

Investors can access the live webcast and replay of the presentation through the 'Upcoming Events' and 'News' sections of Pharming's website.

How can investors schedule meetings with Pharming Group's (PHARM) management team?

Investors can schedule one-to-one meetings by contacting Pharming's Investor Relations team at investor@pharming.com or through their Van Lanschot Kempen or Needham representative.

Who will represent Pharming Group (PHARM) at the Needham Healthcare Conference?

CEO Fabrice Chouraqui and Chief Medical Officer Anurag Relan will represent Pharming Group at the Needham Healthcare Conference.